IL10 receptor is a novel therapeutic target in DLBCLs.
Béguelin W, Sawh S, Chambwe N, Chan FC, Jiang Y, Choo JW, Scott DW, Chalmers A, Geng H, Tsikitas L, Tam W, Bhagat G, Gascoyne RD, Shaknovich R.
Béguelin W, et al. Among authors: choo jw.
Leukemia. 2015 Aug;29(8):1684-94. doi: 10.1038/leu.2015.57. Epub 2015 Mar 3.
Leukemia. 2015.
PMID: 25733167